Clinical Trials in San Antonio

Showing 8381-8400 of 14,633 trials

Phase I Study of HL-085 in Patients With Advanced Solid Tumors

NCT03976050

The study drug, HL-085 is a MEK inhibitor with the potential indication for cancers. It is an oral medication to be given daily. The purposes of this study is to find answers to the following research questions: 1. What is the highest tolerable dose of HL-085 that can be given to subjects when given orally (by mouth) on a twice daily basis? 2. What are the side effects of HL-085? 3. How much HL-085 is in the blood at specific times after dosing and how does the body get rid of the HL-085?

Solid Tumor, Adult

Shanghai Kechow Pharma, Inc.4 participantsStarted Jun 2019

Austin, Texas, United States • San Antonio, Texas, United States

TERMINATEDPhase 2< 1 mile

Efficacy and Safety of Product S2G6T-1in Patients With Symptomatic Inflammatory Interdigital Tinea Pedis

NCT02842021

To assess the efficacy and safety of a combination product S2G6T-1 compared to its monads and vehicle, applied twice daily for 7 days, in the treatment of symptomatic inflammatory interdigital tinea pedis in subjects 12 years of age and older. The results of this study will be utilized to perform power calculations for the Phase 3 pivotal trials.

Tinea Pedis

Sol-Gel Technologies, Ltd.283 participantsStarted Sep 2016

San Diego, California, United States • San Diego, California, United States • Clearwater, Florida, United States +16 more locations

Phase I Study of HL-085 in Patients With Advanced Solid Tumors

Efficacy and Safety of Product S2G6T-1in Patients With Symptomatic Inflammatory Interdigital Tinea Pedis

Find Trials by Condition in San Antonio

Study to Investigate the Safety and Pharmacokinetics of SER120 Nasal Spray in Elderly Patients With Nocturia

Topotecan Liposomes Injection for Small Cell Lung Cancer (SCLC), Ovarian Cancer and Other Advanced Solid Tumors

Bone Mineral Density in Women With Uterine Fibroids or Endometriosis

Dose-finding Study of GLPG0634 as add-on to Methotrexate in Active Rheumatoid Arthritis Participants (DARWIN1)

A Proof-of-Concept Study of Faricimab (RO6867461) in Participants With Choroidal Neovascularization (CNV) Secondary to Age-Related Macular Degeneration (AMD)

Safety and Efficacy of Switching From Dolutegravir and ABC/3TC or ABC/DTG/3TC to B/F/TAF in HIV-1 Infected Adults Who Are Virologically Suppressed

Effect of GTx-024 on Muscle Wasting in Patients With Non-Small Cell Lung Cancer (NSCLC) on First Line Platinum

Efficacy and Safety of IgPro10 in Adults With Systemic Sclerosis (SSc)

A Safety and Efficacy Trial of a Treat and Extend Protocol Using Ranibizumab With and Without Laser Photocoagulation for Diabetic Macular Edema

Ruxolitinib Phosphate in Treating Patients With Chronic Neutrophilic Leukemia or Atypical Chronic Myeloid Leukemia

GreenLight XPS Laser System Retrospective Chart Review

TRANSFIX Zenith® Transection Clinical Study

Investigating Superion™ In Spinal Stenosis

Clinical Study of Cefiderocol (S-649266) for the Treatment of Nosocomial Pneumonia Caused by Gram-negative Pathogens

Randomized Study of Failed SCS Trials Comparing Outcomes Using the Observational Mechanical Gateway (OMG) Connector

A Study of the Efficacy and Safety of JZP-258 in Subjects With Narcolepsy With Cataplexy

A Phase 2 Study to Evaluate the Safety and Efficacy of Intravenously Administered Benralizumab (MEDI-563).

Quality of Life in Patients With Congenital Afibrinogenemia